Mepolizumab (Nucala) is a prescription medication FDA-approved for several eosinophil-related conditions including Hypereosinophilic Syndrome (HES), Eosinophilic Granulomatosis with …

Mepolizumab, sold under the brand name Nucala by GlaxoSmithKline, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic …

Learn more about NUCALA (mepolizumab), a maintenance treatment for patients with severe eosinophilic asthma. NUCALA is not used for sudden breathing problems.

2025年3月12日 · Nucala (mepolizumab) is a biologic therapy used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), and …

Mepolizumab injection is used with other medicines to treat severe asthma. It is given to patients whose asthma is not controlled with their current asthma medicines. It is also used to treat …

2008年3月19日 · Mepolizumab is a fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis …

2014年9月25日 · Patients were assigned to receive mepolizumab, a humanized monoclonal antibody against interleukin-5, which was administered as either a 75-mg intravenous dose or …

Mepolizumab injection is used along with other medications to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in certain children 6 years of age …

NUCALA (mepolizumab) injection, for subcutaneous use • Injection: 100 mg/mL, single-dose, prefilled autoinjector or single-dose Initial U.S. Approval: 2015

Nucala contains the active substance mepolizumab. How is Nucala used? Nucala can only be obtained with a prescription and should be prescribed by a doctor experienced in identifying …